Ghp Investment Advisors Lowers stake in West Pharmaceutical Services (WST)

West Pharmaceutical Services (WST) : Ghp Investment Advisors reduced its stake in West Pharmaceutical Services by 1.52% during the most recent quarter end. The investment management company now holds a total of 38,244 shares of West Pharmaceutical Services which is valued at $3,096,234 after selling 592 shares in West Pharmaceutical Services , the firm said in a disclosure report filed with the SEC on Aug 3, 2016.West Pharmaceutical Services makes up approximately 0.60% of Ghp Investment Advisors’s portfolio.

Other Hedge Funds, Including , Tortoise Investment Management added WST to its portfolio by purchasing 259 company shares during the most recent quarter which is valued at $20,969. West Pharmaceutical Services makes up approx 0.01% of Tortoise Investment Management’s portfolio.Advisory Services Network boosted its stake in WST in the latest quarter, The investment management firm added 48 additional shares and now holds a total of 126 shares of West Pharmaceutical Services which is valued at $9,882.Acadian Asset Management boosted its stake in WST in the latest quarter, The investment management firm added 129 additional shares and now holds a total of 151 shares of West Pharmaceutical Services which is valued at $11,850.Capstone Asset Management Co boosted its stake in WST in the latest quarter, The investment management firm added 4,020 additional shares and now holds a total of 10,416 shares of West Pharmaceutical Services which is valued at $811,615. West Pharmaceutical Services makes up approx 0.02% of Capstone Asset Management Co’s portfolio.Bnp Paribas Arbitrage Sa boosted its stake in WST in the latest quarter, The investment management firm added 28,924 additional shares and now holds a total of 28,978 shares of West Pharmaceutical Services which is valued at $2,239,420. West Pharmaceutical Services makes up approx 0.01% of Bnp Paribas Arbitrage Sa’s portfolio.

West Pharmaceutical Services closed down -1.09 points or -1.33% at $80.64 with 1,70,280 shares getting traded on Monday. Post opening the session at $81.58, the shares hit an intraday low of $80.42 and an intraday high of $81.58 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, West Pharmaceutical Services reported $0.60 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $0.56. The company had revenue of $388.00 million for the quarter, compared to analysts expectations of $384.58 million. The company’s revenue was up 7.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.47 EPS.

West Pharmaceutical Services Inc. is a manufacturer of components and systems for the packaging and delivery of injectable drugs as well as delivery system components for the pharmaceutical healthcare and consumer products industries. The Company’s products include stoppers and seals for vials prefillable syringe components and systems components for intravenous and blood collection systems safety and administration systems advanced injection systems and contract design and manufacturing services. The Company’s customers include producers of pharmaceuticals biologics medical devices and personal care products. The Company’s reportable segments include Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems).

Leave a Reply

West Pharmaceutical Services - Is it time to Sell?

Top Brokerage Firms are advising their investors on West Pharmaceutical Services. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.